VYNE dividend history
VYNE Therapeutics Inc. (VYNE) dividend declarations and ex-dividend dates - real-time wire coverage of every payout disclosure.
Recent dividend items
- VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow BioscienceNEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (NASDAQ:VYNE) ("VYNE" or the "Company") today announced that its previously announced special cash dividend (the "Cash Dividend"), declared in connection with the terms and conditions of the Agreement and Plan of Merger and Reorganization, entered into on December 17, 2025, as amended (the "Merger Agreement"), with Yarrow Bioscience, Inc. ("Yarrow") and Yellow Merger Sub Corp., was distributed, in cash, on July 23, 2026 to VYNE’s stockholders of record as of July 22, 2026 (the "Record Date"), subject to the Nasdaq due bill procedures described below, based on their holdings as of the Record Date and during the Due Bill Per
- VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow BioscienceNEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (NASDAQ:VYNE) ("VYNE" or the "Company") today announced that its Board of Directors has approved a reverse stock split of VYNE’s common stock at a ratio of 1-for-50 in connection with the anticipated closing of the proposed merger (the "Merger") with Yarrow Bioscience, Inc. ("Yarrow"). The reverse stock split was previously approved by VYNE’s stockholders at VYNE’s special meeting in lieu of the annual meeting of stockholders held on July 16, 2026 (the "Special Meeting"). Following the Merger, the combined company’s common stock is expected to begin trading on a post-reverse stock split basis on The Nasdaq Capital Market ("
- VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow BioscienceNEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (NASDAQ:VYNE) ("VYNE" or the "Company") today announced that its Board of Directors has declared a special cash dividend (the "Cash Dividend") in connection with the previously announced merger (the "Merger") with Yarrow Bioscience, Inc. ("Yarrow") pursuant to the Agreement and Plan of Merger and Reorganization, dated December 17, 2025 (as amended, the "Merger Agreement"). The Cash Dividend, which VYNE estimates will be an aggregate of $16.5 million, or an estimated $0.38 per share, will be payable in cash to the stockholders and warrant holders of record as of July 22, 2026. The estimated cash dividend is based on VYNE’s g